title: Authors' reply to Sasich and Linden.
authors.affiliation: School of Medical Sciences, Bangor University, Bangor, Wales, UK.
authors.forename: Joanna
authors.initials: J
authors.lastname: Le Noury
authors.affiliation: Emory University, Atlanta, GA, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Nardo
authors.affiliation: School of Medical Sciences, Bangor University, Bangor, Wales, UK.
authors.forename: David
authors.initials: D
authors.lastname: Healy
authors.affiliation: Critical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia Jon.Jureidini@adelaide.edu.au.
authors.forename: Jon
authors.initials: J
authors.lastname: Jureidini
authors.affiliation: Critical and Ethical Mental Health Research Group, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
authors.forename: Melissa
authors.initials: M
authors.lastname: Raven
authors.affiliation: Joanna Briggs Institute, Faculty of Health Sciences, University of Adelaide.
authors.forename: Catalin
authors.initials: C
authors.lastname: Tufanaru
authors.affiliation: Department of Psychiatry, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
authors.forename: Elia
authors.initials: E
authors.lastname: Abi-Jaoude
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D017374:Paroxetine / Q000627:therapeutic use*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D007099:Imipramine